Literature DB >> 22033803

Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics.

Heidrun Appl1, Tobias Holzammer, Stefan Dove, Ekkehard Haen, Andrea Strasser, Roland Seifert.   

Abstract

Antidepressants and antipsychotics affect multiple molecular targets. Consequently, these drugs exhibit not only unique profiles of therapeutic effects but also several undesired effects. Histamine receptors (H₁R, H₂R, H₃R, and H₄R) belong to the large family of G protein-coupled receptors and are very important drug targets. All four H(x)R subtypes are expressed in the CNS. Interactions of lipophilic, blood-brain barrier-penetrating drugs with H(x)Rs could contribute to therapeutic and unwanted effects. Therefore, we investigated potencies H(x)R as well as potencies and (inverse) agonistic efficacies of 34 antidepressants and antipsychotics at HxRs in functional assays. We expressed human H(x)Rs in Sf9 insect cells and conducted radioligand competition binding experiments and functional steady-state GTPase assays. Ligand affinities and potencies were compared with literature data and related to therapeutic reference ranges. Almost all antidepressants and antipsychotics displayed high binding affinities to H₁R and behaved as antagonists. The atypical antidepressant trimipramine behaved as a high-affinity/high-potency H₂R antagonist (pK(i), 7.39; pK(B), 7.36; pA₂, 7.55). Docking to an H₂R model suggested a probable binding mode. The affinity of antidepressants and antipsychotics for H₃R was low. The atypical antipsychotic clozapine, known to induce agranulocytosis, exhibited partial H₄R agonism for which docking experiments provided a molecular basis. Clozapine also exhibited H₂R antagonism. We observed dissociations between pK(i) and pK (B) values as well as between pK(i) and pIC₅₀ values for H(x)Rs. Antidepressants and antipsychotics interact differentially with H(x)Rs. The concept of functional selectivity (also referred to as ligand-specific receptor conformations or biased signaling) explains dissociations between pK(i) and pK(B) values as well as differences between pK(i) and pIC₅₀ values. The H₁R antagonism of numerous antidepressants and antipsychotics is very pronounced. The H₂R antagonism of trimipramine and partial H₄R agonism of clozapine may be clinically relevant. We also discuss the possible role of the H₂R antagonism of clozapine for neutropenia/agranulocytosis induced by this compound. Finally, we discuss the methodological, conceptual, and clinical limitations of our study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033803     DOI: 10.1007/s00210-011-0704-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  103 in total

1.  Clozapine is cytotoxic to primary cultures of human bone marrow mesenchymal stromal cells.

Authors:  Liisa Lahdelma; Sofia Oja; Matti Korhonen; Leif C Andersson
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

2.  Agranulocytosis associated with initiation of famotidine therapy.

Authors:  Esther-Lee Marcus; A Mark Clarfield; Yosef Kleinman; Helena Bits; David Darmon; Nael Da'as
Journal:  Ann Pharmacother       Date:  2002-02       Impact factor: 3.154

3.  Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists.

Authors:  M T Kelley; T Bürckstümmer; K Wenzel-Seifert; S Dove; A Buschauer; R Seifert
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

Review 4.  Trimipramine: a challenge to current concepts on antidepressives.

Authors:  M Berger; M Gastpar
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

5.  Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.

Authors:  T Costa; J Lang; C Gless; A Herz
Journal:  Mol Pharmacol       Date:  1990-03       Impact factor: 4.436

6.  Mutational analysis of the antagonist-binding site of the histamine H(1) receptor.

Authors:  K Wieland; A M Laak; M J Smit; R Kühne; H Timmerman; R Leurs
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

7.  Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Marc Kunze; Sigurd Elz; Roland Seifert
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

Review 8.  The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines.

Authors:  Robin L Thurmond; Erwin W Gelfand; Paul J Dunford
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

9.  Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation.

Authors:  Mohamed Rafiuddin Ahmed; Vsevolod V Gurevich; Kevin N Dalby; Jeffrey L Benovic; Eugenia V Gurevich
Journal:  J Pharmacol Exp Ther       Date:  2008-01-04       Impact factor: 4.030

10.  Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.

Authors:  Aldo Jongejan; Herman D Lim; Rogier A Smits; Iwan J P de Esch; Eric Haaksma; Rob Leurs
Journal:  J Chem Inf Model       Date:  2008-06-14       Impact factor: 4.956

View more
  16 in total

Review 1.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

2.  Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-24       Impact factor: 3.000

3.  New perspectives for a well-known biogenic amine: mast cell-derived histamine as pathophysiological agent in vincristine-induced neuropathic pain.

Authors:  Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-19       Impact factor: 3.000

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 5.  Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System.

Authors:  Erich H Schneider; Roland Seifert
Journal:  Handb Exp Pharmacol       Date:  2017

Review 6.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

Review 7.  Molecular and cellular analysis of human histamine receptor subtypes.

Authors:  Roland Seifert; Andrea Strasser; Erich H Schneider; Detlef Neumann; Stefan Dove; Armin Buschauer
Journal:  Trends Pharmacol Sci       Date:  2012-12-17       Impact factor: 14.819

8.  Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor--H1/H4 receptor selectivity.

Authors:  Eva Wagner; Hans-Joachim Wittmann; Sigurd Elz; Andrea Strasser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-17       Impact factor: 3.000

9.  Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity.

Authors:  Irena Brunskole Hummel; Michael T Reinartz; Solveig Kälble; Heike Burhenne; Frank Schwede; Armin Buschauer; Roland Seifert
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor.

Authors:  Carolin Lübker; Roland Seifert
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.